Fingerprint
Dive into the research topics of 'Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning
J. Kline, D. A. Pollyea, W. Stock, A. Artz, E. Rich, L. Godley, T. Zimmerman, K. Thompson, K. Pursell, R. A. Larson, K. van Besien*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
43
Scopus
citations